CBGRX
Price
$14.11
Change
-$0.04 (-0.28%)
Updated
Jul 13 closing price
Net Assets
813.13M
RBFFX
Price
$11.14
Change
-$0.04 (-0.36%)
Updated
Jul 13 closing price
Net Assets
100.75B
Interact to see
Advertisement

CBGRX vs RBFFX

CBGRX vs RBFFX Comparison Chart in %
View a ticker or compare two or three
VS
CBGRX vs. RBFFX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CBGRX is a Hold and RBFFX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RBFFX has more cash in the bank: 101B vs. CBGRX (813M). RBFFX pays higher dividends than CBGRX: RBFFX (4.44) vs CBGRX (3.82). CBGRX was incepted earlier than RBFFX: CBGRX (7 years) vs RBFFX (24 years). CBGRX (0.44) is less costly to investors than RBFFX (0.28). RBFFX is a more actively managed with annual turnover of: 90.00 vs. CBGRX (22.00). RBFFX has a lower initial minimum investment than CBGRX: RBFFX (250) vs CBGRX (5000000). CBGRX annual gain was more profitable for investors over the last year : 3.77 vs. RBFFX (3.57). CBGRX return over 5 years is better than : 0.90 vs. RBFFX (-0.58).
CBGRXRBFFXCBGRX / RBFFX
Total Expense Ratio0.430.28154%
Annual Report Gross Expense Ratio0.440.28157%
Fund Existence7 years24 years-
Gain YTD0.177-0.570-31%
Front LoadN/AN/A-
Min. Initial Investment50000002502,000,000%
Min. Initial Investment IRAN/AN/A-
Net Assets813M101B1%
Annual Yield % from dividends3.824.4486%
Returns for 1 year3.773.57106%
Returns for 3 years14.1711.98118%
Returns for 5 years0.90-0.58-154%
Returns for 10 yearsN/A15.12-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
FMED29.56N/A
N/A
Fidelity Disruptive Medicine ETF
MYCF25.01N/A
N/A
State Street® My2026 Corporate Bond ETF
TPLS24.98N/A
N/A
Thornburg Core Plus Bond ETF
BGH14.14-0.06
-0.42%
Barings Global Short Duration High Yield Fund
EMGF69.07-2.55
-3.56%
iShares Em Mkts Eq Fac ETF